NeuroSense Therapeutics L... (NRSNW)

AI Score

Unlock

0.26

0.06 (32.79%)

At close: Apr 17, 2025, 12:47 PM

0.26

0.00%

After-hours: Apr 17, 2025, 04:00 PM EDT

NeuroSense Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Mar 31, 2020
Cash & Equivalents	3.38M	344K	1.21M	771K	2.68M	4.76M	7.09M	1.36M	3.54M	4.41M	4.35M	8.73M	11.06M	994K	-699K	699K	699K	-895K
Short-Term Investments	n/a	n/a	35K	n/a	n/a	n/a	n/a	3.05M	3.55M	4.03M	6.03M	5M	n/a	n/a	1.4M	n/a	n/a	1.79M
Long-Term Investments	n/a	n/a	n/a	23K	22K	21K	23K	23K	23K	34K	35K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	23K	23K	22K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	37K	-699K	37K	n/a	-895K
Receivables	164K	406K	376K	421K	166K	309K	434K	567K	131K	425K	707K	225K	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	-457K	n/a	36.65K	37.53K	38.39K	-3.68M	n/a	n/a	-225K	-178K	-16K	n/a	-67K	n/a	n/a
Other Current Assets	35K	35K	n/a	n/a	n/a	346.00	472.00	606.00	36K	23K	23K	64K	349K	n/a	n/a	67K	67K	n/a
Total Current Assets	4.4M	785K	1.62M	1.19M	2.92M	5.11M	7.56M	5.02M	7.38M	8.89M	11.1M	14.03M	11.41M	1.01M	699K	729K	766K	895K
Property-Plant & Equipment	150K	176K	200K	231K	238K	260K	284K	294K	306K	304K	314K	329K	19K	15K	n/a	13K	13K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	173K	199K	222K	254K	260K	281K	307K	317K	329K	338K	349K	329K	19K	52K	-699K	50K	13K	-895K
Total Assets	4.58M	984K	1.84M	1.45M	3.18M	5.39M	7.87M	5.33M	7.71M	9.23M	11.45M	14.36M	11.43M	1.06M	n/a	779K	779K	n/a
Account Payables	1.16M	1.39M	1.48M	2.38M	1.46M	913K	1.09M	419K	498K	206K	120K	180K	39K	12K	n/a	55K	55K	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	n/a	n/a	2.02M	2.15M	614K	1.9M	1.92M	1.37M	413K	605K	616K	1.05M	n/a	n/a	n/a	n/a	65K	n/a
Total Current Liabilities	1.99M	3.78M	3.51M	4.54M	3.46M	2.81M	3M	1.79M	1.73M	811K	736K	1.23M	597K	125K	n/a	120K	120K	n/a
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	147K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	3.85M	1.52M	2.69M	6.3M	527K	71K	400K	691K	816K	1.83M	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	19K	36K	3.9M	1.59M	2.77M	6.41M	653K	365K	573K	881K	1.02M	1.83M	n/a	n/a	n/a	n/a	n/a
Total Liabilities	1.99M	3.8M	3.54M	8.44M	5.05M	5.58M	9.41M	2.45M	2.09M	1.38M	1.62M	2.25M	2.42M	125K	n/a	120K	120K	n/a
Total Debt	73K	19K	36K	55K	142K	84K	104K	126K	211K	173K	190K	207K	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Retained Earnings	-36.66M	-34.53M	-32.38M	-31.52M	-32.07M	-29.12M	-29.9M	-24.68M	-20.79M	-17.64M	-14.64M	-11.16M	-8.45M	-7.46M	n/a	-4.41M	-4.41M	n/a
Comprehensive Income	n/a	n/a	n/a	24.53M	30.19M	28.92M	28.36M	27.56M	26.41M	25.48M	24.48M	23.27M	-0.00	n/a	659K	n/a	n/a	918K
Shareholders Equity	2.58M	-2.82M	-1.7M	-6.99M	-1.87M	-196K	-1.54M	2.89M	5.62M	7.85M	9.84M	12.11M	9.01M	937K	659K	659K	659K	918K
Total Investments	n/a	n/a	22K	23K	22K	21K	23K	3.05M	3.55M	4.03M	6.03M	5M	n/a	n/a	1.4M	n/a	n/a	1.79M